Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ilaria Cavallo
Observed name:
I. Cavallo
Institution:
Fondazione IRCCS Istituto Nazionale dei Tumori
Observed institutions:
ASST Melegnano e della Martesana,
Ospedale SS. Annunziata,
Fondazione IRCCS Istituto Nazionale dei Tumori
ORCID:
0009-0002-4866-0326
Observed ORCID:
0009-0002-4866-0326
OpenAlex ID:
A5103227541
Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study
2016
·
Roberto Agresti
, Elisabetta Meneghini
, et al.
·
Breast Cancer Research and Treatment
·
51
Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients
2019
·
Marcello Di Nisio
, Nick van Es
, et al.
·
Journal of Thrombosis and Thrombolysis
·
36
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study
2024
·
Monica Niger
, Federico Nichetti
, et al.
·
BMC Cancer
·
25
PDF
A Breast Cancer Clinical Registry in An Italian Comprehensive Cancer Center: An Instrument for Descriptive, Clinical, and Experimental Research
2015
·
Paolo Baili
, Michele Torresani
, et al.
·
Tumori Journal
·
12
From Real-World Data to Causally Interpretable Models: A Bayesian Network to Predict Cardiovascular Diseases in Adolescents and Young Adults with Breast Cancer
2024
·
Alice Bernasconi
, Alessio Zanga
, et al.
·
Cancers
·
11
PDF
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study
2024
·
Monica Niger
, Federico Nichetti
, et al.
·
BMC Cancer
·
5
Radiochemotherapy for salivary gland adenoid cystic carcinoma: survival assessment through a retrospective study exploiting real-world data extracted from data warehouse
2025
·
S. Cavalieri
, B. Lombardi Stocchetti
, et al.
·
ESMO Real World Data and Digital Oncology
·
4
PDF
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2
2025
·
Giacomo Mazzoli
, Leonardo Provenzano
, et al.
·
The Breast
·
4
PDF
PH-0604 Hippocampal Sparing WBRT: Trade-Off Between Tumor Control And Quality Of Life? A series of 150 pts
2021
·
G. Corrao
, L. Bergamaschi
, et al.
·
Radiotherapy and Oncology
·
2
Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study
2026
·
Francesca Ligorio
, Leonardo Provenzano
, et al.
·
The Breast
·
1
Il turn-over del personale con contratti di lavoro flessibili o borse di studio dedicato alla ricerca sanitaria in un IRCCS pubblico italiano
2019
·
Elisabetta Meneghini
, Roberto Lillini
, et al.
·
Recenti Progressi in Medicina
·
1
125P Clinical-radiomic two-stage triage to optimize OncotypeDX testing in HR+/HER2- early breast cancer
2026
·
E. Totis
, L. Provenzano
, et al.
·
ESMO Real World Data and Digital Oncology
PDF
Prognostic value of hormone receptor expression in patients with HR+/HER2− advanced BC treated with first-line ET+CDK4/6i: results from the multicentre observational, real-world PALMARES-2 study
2026
·
Francesca Ligorio
, Leonardo Provenzano
, et al.
·
EClinicalMedicine
Single Cancer Center Experience on Patient Blood Management Eligibility in Oncological Surgery
2026
·
Camilla L’Acqua
, Roberto Lillini
, et al.
·
Journal of Clinical Medicine
PDF
56P CT-based radiomics to predict HER2 expression of metastases from breast cancer: Preliminary results from the RADIOSPHER2 study
2025
·
L. Provenzano
, E. Totis
, et al.
·
ESMO Real World Data and Digital Oncology
A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of Ovarian Cancer: a Single Center, Open Label, Single Arm, Phase Ib/ii Trial (nichol Trial Nct06594679)
2025
·
Monika Ducceschi
, Salvatore Lopez
, et al.
·
International Journal of Gynecological Cancer
PO-1255: Prognostic factors in brain metastases from breast cancer treated with Cyberknife
2020
·
G. Riva
, A. Ferrari
, et al.
·
Radiotherapy and Oncology
PO-0937: Partial breast re-irradiation with IMRT for local recurrence after whole breast radiotherapy
2020
·
S. Arculeo
, S. Frassoni
, et al.
·
Radiotherapy and Oncology
Show more works
View as search
Works count:
18
Citation count:
152
H-index:
5
I10-index:
5
Year
Topic
Type